EGFR and cancer prognosis

European Journal of Cancer

Volumn 37, Issue SUPPL. 4, 2001, Pages 9-

  Nicholson, R I ^a   Gee, J M W ^a   Harper, M E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Epidermal growth factor; ErbB 2; Neoplasms; Prognosis; Receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; ESOPHAGUS CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; LUNG NON SMALL CELL CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

EID: 0034778447     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00231-3     Document Type: Article

References (38)

1. Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results
2. Epidermal growth factor-related peptides and their receptors in human malignancies
3. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma
4. EGFR and steroid receptors in ovarian carcinoma: Comparison with prognostic parameters and outcome of patients
5. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis
6. Long-term outcome related to epidermal growth factor receptor status in bladder cancer
7. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)
8. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy
9. Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers
10. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells
11. In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-alpha
12. Transforming growth factor alpha and mouse models of human breast cancer
13. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer
14. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients
15. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma
16. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors
17. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: Correlation to clinical features
18. Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer
19. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma
20. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas
21. Comparative evaluation of cell proliferative indices and epidermal growth factor receptor expression in gastric carcinomas
22. The role of endoscopic ultrasonography and epidermal growth factor receptor assay in preoperative staging for gastric carcinoma
23. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer
24. Clinical study on epidermal growth factor and its receptor in human gastric cancer
25. erbB signalling and endocrine sensitivity of human breast cancer
26. Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy
27. Transforming growth factor-alpha and endocrine sensitivity in breast cancer
28. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor and mdr gene expression in colorectal cancer
29. Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas
30. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer
31. Epidermal growth factor receptor expression in colorectal cancer
32. Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma
33. Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival
34. The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer
35. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung
36. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
37. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
38. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma